V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280004624 | 280003153 | 1.6 | 70.4 | Curative (C) | 2018-03-20 | 2018-03-21 | CARBOPLATIN + PACLITAXEL | N | null | 280027663 | CARBOPLATIN + PACLITAXEL |
| 280004625 | 280003153 | 1.7 | 90.6 | Curative (C) | 2014-05-19 | 2014-05-19 | Carboplatin + Etoposide iv&po | N | N | 280027663 | CARBOPLATIN + ETOPOSIDE |
| 280004626 | 280003153 | null | 65 | Adjuvant (A) | 2016-11-12 | 2016-12-17 | CARBOPLATIN | N | Y | 280027663 | CARBOPLATIN |
| 280004627 | 280003153 | 1.74 | 69.9 | Curative (C) | 2015-02-09 | 2015-02-15 | Carboplatin + Paclitaxel (3 weekly) | N | N | 280027663 | CARBOPLATIN + PACLITAXEL |
| 280004628 | 280003153 | 1.68 | null | Curative (C) | 2016-03-02 | 2016-03-10 | CARBOPLATIN + PACLITAXEL | Y | Y | 280027663 | CARBOPLATIN + PACLITAXEL |
| 280004629 | 280003153 | 1.65 | 68 | Curative (C) | 2013-12-04 | 2013-12-07 | CARBOPLATIN + RT | 02 | N | 280027663 | CARBOPLATIN + RT |
| 280004630 | 280003153 | 1.85 | 92.8 | Curative (C) | 2015-02-06 | 2015-09-19 | STS Rhabdomyosarcoma RMS 2005 IVAVV | 2 | N | 280027663 | NOT MATCHED |
| 280004631 | 280003154 | 1.67 | 100.7 | Curative (C) | null | 2017-09-07 | CARBOPLATIN + RT | null | null | 280027675 | CARBOPLATIN + RT |
| 280004632 | 280007608 | 1.56 | 62.5 | Curative (C) | 2018-01-25 | 2018-02-01 | CETUXIMAB | 02 | null | 280027677 | CETUXIMAB |
| 280004633 | 280007608 | 1.75 | 95.5 | null | 2013-12-16 | 2013-12-25 | Cisplatin + Gemcitabine (D 1 & 8) | Y | N | 280027677 | CISPLATIN + GEMCITABINE |
| 280004634 | 280003155 | 1.71 | 95.6 | Curative (C) | 2013-10-30 | 2013-11-09 | Carboplatin + Paclitaxel (3 weekly) | null | null | 280027679 | CARBOPLATIN + PACLITAXEL |
| 280004635 | 280003156 | null | 0 | null | 2014-01-26 | 2014-01-27 | CARBOPLATIN + RT | N | N | 280027680 | CARBOPLATIN + RT |
| 280004636 | 280003156 | 1.8 | 76 | Curative (C) | 2017-01-13 | 2017-02-21 | CARBOPLATIN + ETOPOSIDE | 02 | N | 280027680 | CARBOPLATIN + ETOPOSIDE |
| 280004637 | 280003157 | 1.88 | 9.4 | Curative (C) | 2017-09-06 | 2017-10-04 | Trial Unspecified | 2 | N | 280027682 | TRIAL |
| 280004638 | 280003158 | 1.62 | 51.5 | null | 2015-12-07 | 2015-12-07 | Carboplatin + Etoposide IV 3 day | 2 | Y | 280027683 | CARBOPLATIN + ETOPOSIDE |
| 280004639 | 280003159 | 0 | 68.6 | Curative (C) | 2015-08-27 | 2015-08-31 | Olaratumab | 02 | N | 280027684 | NOT MATCHED |
| 280004640 | 280003160 | 1.63 | 84.7 | Curative (C) | 2015-11-11 | 2015-11-17 | Carboplatin + Paclitaxel (3 weekly) | N | N | 280027685 | CARBOPLATIN + PACLITAXEL |
| 280004641 | 280003161 | 1.7 | 100 | Curative (C) | 2015-08-21 | 2015-08-22 | Carboplatin 21day + Paclitaxel 7day | 2 | N | 280027686 | CARBOPLATIN + PACLITAXEL |
| 280004642 | 280003161 | 1.85 | 59 | Curative (C) | 2014-05-16 | 2014-05-16 | Trial Unspecified | 2 | N | 280027686 | TRIAL |
| 280004643 | 280003162 | 0 | 83.2 | null | 2015-05-22 | 2015-05-22 | STS Rhabdomyosarcoma RMS 2005 IVAVV | Y | N | 280027692 | NOT MATCHED |
| 280004644 | 280003163 | 1.54 | 74.4 | Curative (C) | null | 2016-01-14 | Cetuximab 7 day (Cycle 1) | 02 | null | 280027698 | CETUXIMAB |
| 280004645 | 280003163 | null | 99.4 | Curative (C) | 2015-04-09 | 2015-05-07 | Carboplatin AUC 6 - 10 | N | Y | 280027698 | CARBOPLATIN |
| 280004646 | 280003163 | null | 82 | Curative (C) | 2017-11-24 | 2017-12-14 | EOX | 2 | Y | 280027698 | EOX |
| 280004647 | 280003163 | 1.52 | 70.2 | Curative (C) | null | 2017-12-07 | Cisplatin + Gemcitabine (D 1 & 8) | N | null | 280027698 | CISPLATIN + GEMCITABINE |
| 280004648 | 280003163 | 1.76 | 92.51 | Curative (C) | null | 2014-07-16 | Trial Unspecified | 02 | N | 280027698 | TRIAL |
| 280004649 | 280003163 | 0 | 73.8 | Curative (C) | 2013-05-21 | 2013-05-21 | Trial Unspecified | 02 | null | 280027698 | TRIAL |
| 280004650 | 280003163 | 1.7 | 58.2 | Curative (C) | 2017-09-25 | 2017-10-05 | Carboplatin + Paclitaxel (3 weekly) | Y | N | 280027698 | CARBOPLATIN + PACLITAXEL |
| 280004651 | 280003164 | 1.71 | 116.8 | Neo-adjuvant (N) | 2014-07-18 | 2014-07-26 | Carboplatin + Paclitaxel (3 weekly) | N | Y | 280027711 | CARBOPLATIN + PACLITAXEL |
| 280004652 | 280003165 | 1.61 | 63.8 | Adjuvant (A) | 2015-04-02 | 2015-04-07 | CETUXIMAB | N | N | 280027713 | CETUXIMAB |
| 280004653 | 280003165 | 1.78 | 82.2 | null | 2016-01-27 | 2016-01-27 | Cetuximab 7 day (Cycle 1) | N | N | 280027713 | CETUXIMAB |
| 280004654 | 280009884 | 1.88 | 88.8 | Adjuvant (A) | 2013-08-03 | 2013-09-02 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 280027717 | CISPLATIN + GEMCITABINE |
| 280004655 | 280009884 | 1.79 | null | Neo-adjuvant (N) | 2016-12-27 | 2017-01-01 | CETUXIMAB | N | Y | 280027717 | CETUXIMAB |
| 280004656 | 280003166 | 1.8 | 66 | Curative (C) | 2016-08-01 | 2016-08-05 | EOX | null | null | 280027719 | EOX |
| 280004657 | 280003167 | null | 86.4 | Curative (C) | 2016-11-04 | 2016-11-25 | NB Low/Interm risk guidelines Carbo/Etop | Y | Y | 280027720 | NOT MATCHED |
| 280004658 | 280003167 | 0 | 58.2 | Adjuvant (A) | 2016-02-04 | 2016-02-15 | STS Rhabdomyosarco RMS 2005 IVADoVV | N | N | 280027720 | NOT MATCHED |
| 280004659 | 280003167 | 1.69 | 86.3 | Palliative (P) | 2017-12-10 | 2017-12-10 | EOX | Y | N | 280027720 | EOX |
| 280004660 | 280003167 | 1.61 | 112.2 | Curative (C) | 2015-10-25 | 2015-10-28 | CISPLATIN + GEMCITABINE | N | Y | 280027720 | CISPLATIN + GEMCITABINE |
| 280004661 | 280003168 | 1.8 | 79 | Curative (C) | 2013-12-13 | 2014-01-04 | EOX | 02 | N | 280027727 | EOX |
| 280004662 | 280003168 | 1.54 | 73 | Curative (C) | 2017-07-16 | 2017-07-19 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | null | 280027727 | CISPLATIN + GEMCITABINE |
| 280004663 | 280003169 | null | 80 | Curative (C) | null | 2018-07-12 | Trial Unspecified | 2 | N | 280027732 | TRIAL |
| 280004664 | 280003169 | 1.7 | null | Neo-adjuvant (N) | 2015-09-05 | 2015-09-10 | EOX | N | N | 280027732 | EOX |
| 280004665 | 280003169 | 1.61 | 79 | Palliative (P) | 2016-09-19 | 2016-10-11 | CISPLATIN + GEMCITABINE | 2 | N | 280027732 | CISPLATIN + GEMCITABINE |
| 280004667 | 280007616 | 1.8 | 80 | Palliative (P) | 2018-01-05 | 2018-01-09 | Trial Unspecified | 2 | N | 280027741 | TRIAL |
| 280004668 | 280003171 | 1.45 | 69 | Curative (C) | 2013-06-10 | 2013-06-10 | CARBOPLATIN | Y | null | 280027742 | CARBOPLATIN |
| 280004669 | 280003171 | 1.69 | 65 | Neo-adjuvant (N) | 2017-05-20 | 2017-05-25 | Carboplatin + Paclitaxel (3 weekly) | N | Y | 280027742 | CARBOPLATIN + PACLITAXEL |
| 280004670 | 280003172 | 1.78 | 83.1 | Curative (C) | 2013-04-23 | 2013-04-26 | CARBOPLATIN + RT | null | Y | 280027746 | CARBOPLATIN + RT |
| 280004671 | 280003173 | 1.62 | 12 | Curative (C) | 2017-09-28 | 2017-09-28 | CARBOPLATIN | 02 | Y | 280027748 | CARBOPLATIN |
| 280004672 | 280003174 | 1.85 | 70 | Curative (C) | 2016-01-16 | 2016-01-16 | Carboplatin AUC 2 - 5 | 2 | N | 280027751 | CARBOPLATIN |
| 280004673 | 280007618 | null | 95.5 | Curative (C) | 2016-12-11 | 2016-12-18 | Trial Unspecified | null | Y | 280027753 | TRIAL |
| 280004674 | 280003175 | 1.65 | 58 | Palliative (P) | 2015-03-01 | 2015-03-07 | NB HRNBL-1 COJEC Ind COURSE A | Y | N | 280027754 | NOT MATCHED |